![[Industry Direct] PHI Studio & Agog Are Seeking Immersive Artists for a Four Week Residency Program](https://roadtovrlive-5ea0.kxcdn.com/wp-content/uploads/2025/05/phi-immersive-residency-2-341x220.jpg?#)
Vertex touts promising launch for non-opioid pain drug Journavx
Vertex said it's gathering momentum with its new product launches, building out new franchises with its sickle cell therapy Casgevy, another cystic fibrosis drug in Alyftrek, and the non-opioid pain drug Journavx. Journavx, which was ...
Vertex said it's gathering momentum with its new product launches, building out new franchises with its sickle cell therapy Casgevy, another cystic fibrosis drug in Alyftrek, and the non-opioid pain drug Journavx.
Journavx, which was ...
